Shares of profitable rare disease specialist Catalyst Pharmaceuticals (CPRX) are 3% in the red for 2024 and +9% for trailing twelve months. On the other hand, 3-year gain is a whopping +318% and +444% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results